These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36379889)

  • 1. [Comparison of programmed death-ligand 1 protein expression between primary tumors and lymph node metastatic lesions in oral squamous cell carcinoma].
    Xia RH; Hu YH; Zhang CY; Xu SM; Li J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Nov; 57(11):1113-1118. PubMed ID: 36379889
    [No Abstract]   [Full Text] [Related]  

  • 2. PD-L1 expression in head and neck carcinoma by combined positive score: a comparison among preoperative biopsy, tumor resection, and lymph node metastasis.
    Ambrosini-Spaltro A; Limarzi F; Gaudio M; Calpona S; Meccariello G
    Virchows Arch; 2022 Jul; 481(1):93-99. PubMed ID: 35420378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed death-ligand expression and lymph node involvement in penile squamous cell carcinoma.
    Peyroteo I; Santos F; Marialva C; Brito Ramos R
    Arch Ital Urol Androl; 2024 Oct; 96(3):12856. PubMed ID: 39356010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.
    Saeed S; Rauf F; Iqbal F; Khan AS; Khan AH; Alamgeer R
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4039-4045. PubMed ID: 36579984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma.
    Liu Z; Williams M; Stewart J; Glisson BS; Fuller C; Roy-Chowdhuri S
    Cancer Cytopathol; 2022 Feb; 130(2):110-119. PubMed ID: 34375025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of Expression of PD-1 and PD-L1 In Head And Neck Squamous Cell Carcinoma And their Association With Nodal Metastasis: A Cross-Sectional Study.
    Malik IS; Asif M; Bashir N; Ara N; Rashid F; Din HU; Malik NS; Bashir A
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):467-473. PubMed ID: 35225458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the programmed death ligand-1 combined positive score in tumors and clinicopathological features in esophageal cancer.
    Huang Z; Jin Y; Cai X; Chen L; Shen X; Li B; Chen H; Li Y
    Thorac Cancer; 2022 Feb; 13(4):523-532. PubMed ID: 34953041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed Death Ligand-1 Combined Positive Score Concordance and Interrater Reliability in Primary Tumors and Synchronous Lymph Node Metastases in Resected Cases of p16+ Oropharyngeal Squamous Cell Carcinoma.
    Kaur A; Kuchta K; Watkin W; Sullivan M; Liu L; Jamshidi P; Campbell N; Brockstein B; Paintal A
    Arch Pathol Lab Med; 2023 Apr; 147(4):442-450. PubMed ID: 35862863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study).
    Lorini L; Zigliani G; Morbini P; Salviato E; Piazza C; Battocchio S; Preda L; Benazzo M; Ravanelli M; Mattavelli D; Bossi P
    Oral Oncol; 2024 Oct; 157():106950. PubMed ID: 39038413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIM2 promotes irradiation resistance, migration ability and PD-L1 expression through STAT1/NF-κB activation in oral squamous cell carcinoma.
    Chiu HW; Lee HL; Lee HH; Lu HW; Lin KY; Lin YF; Lin CH
    J Transl Med; 2024 Jan; 22(1):13. PubMed ID: 38166970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof.
    Chen TC; Wu CT; Wang CP; Hsu WL; Yang TL; Lou PJ; Ko JY; Chang YL
    Oral Oncol; 2015 Nov; 51(11):1004-1010. PubMed ID: 26365985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinicopathological significance of PD-L1 expression assessed by the combined positive score (CPS) in head and neck squamous cell carcinoma.
    Wusiman D; Guo L; Huang Z; Li Z; Liu S; Ying J; Li W; An C
    Pathol Res Pract; 2022 Aug; 236():153934. PubMed ID: 35691098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma.
    Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial Intratumoral Heterogeneity Expression of PD-L1 Antigen in Head and Neck Squamous Cell Carcinoma.
    Hirshoren N; Al-Kharouf I; Weinberger JM; Eliashar R; Popovtzer A; Knaanie A; Fellig Y; Neuman T; Meir K; Maly A; Vainer GW
    Oncology; 2021; 99(7):464-470. PubMed ID: 33789303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of PD-L1 and PD-L2 in neck node metastases of head and neck squamous cell carcinoma.
    Moratin J; Metzger K; Safaltin A; Herpel E; Hoffmann J; Freier K; Hess J; Horn D
    Head Neck; 2019 Aug; 41(8):2484-2491. PubMed ID: 30821864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
    Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
    J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD-L1 and PD-L2.
    Sato R; Komatsuda H; Inoue T; Wakisaka R; Kono M; Yamaki H; Ohara K; Kumai T; Kishibe K; Hayashi T; Takahara M
    Head Neck; 2024 Sep; 46(9):2233-2243. PubMed ID: 38665131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 expression in ovarian clear cell carcinoma using the 22C3 pharmDx assay.
    Gao Y; Pan B; Jia H; Zhang Y; Wang S; Wang Y; Zhang S; Li M; Wang A; Wang X; Zhao K; Zhang Z; Sun J; Guo D; Liang Z
    Diagn Pathol; 2024 Jun; 19(1):82. PubMed ID: 38879528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 expression in bladder cancer: Which scoring algorithm in what tissue?
    Schulz GB; Todorova R; Braunschweig T; Rodler S; Volz Y; Eismann L; Pfitzinger P; Jokisch F; Buchner A; Stief C; Mayr D; Casuscelli J
    Urol Oncol; 2021 Oct; 39(10):734.e1-734.e10. PubMed ID: 34261585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.